Economic Analysis of Integrating Digital Cognitive Assessments and Blood‐Based Biomarker Testing in Alzheimer's Screening Workflow

Abstract

Background: The rising prevalence of dementia and the growing availability of disease‐modifying therapies (DMTs) emphasize the need for efficient and scalable diagnostic pathways. Current health system constraints in capacity and accessibility pose challenges in identifying patients eligible for DMTs.

The paper